Sugi Predict

Sugi Predict / Compounds / SCHEMBL23593158

SCHEMBL23593158

SCHEMBL23593158

CC1(C)c2ccc(-c3ccc(N(c4ccc(-c5ccccc5)cc4)c4ccc(-c5ccc6ccccc6c5)cc4)cc3)cc2-c2sc3ccccc3c21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ S1PR5 Q9H228 8/20 0.36
▸ S1PR4 O95977 6/20 0.36
▸ CNR1 P21554 2/20 0.33
▸ CNR2 P34972 2/20 0.33
▸ CHRNA1 P02708 1/20 0.33
▸ CHRNG P07510 1/20 0.33
▸ CHRNB1 P11230 1/20 0.33
▸ CHRNB2 P17787 1/20 0.33
▸ SLC6A2 P23975 1/20 0.33
▸ CHRNB4 P30926 1/20 0.33
▸ SLC6A4 P31645 1/20 0.33
▸ CHRNA3 P32297 1/20 0.33
▸ CHRNA4 P43681 1/20 0.33
▸ SLC6A3 Q01959 1/20 0.33
▸ CHRND Q07001 1/20 0.33
▸ LPL P06858 1/20 0.33
▸ LIPG Q9Y5X9 1/20 0.33
▸ ALK Q9UM73 1/20 0.32
▸ ITGA4 P13612 1/20 0.32
▸ NAPEPLD Q6IQ20 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23592247 0.97 S1PR5 (0.33) S1PR5S1PR4CNR1CNR2CHRNA1
SCHEMBL23593152 0.96 ALK (0.32) S1PR5S1PR4CNR1CNR2ALK
SCHEMBL23593145 0.93 ALK (0.33) CNR1CNR2ALKITGA4NAPEPLD
SCHEMBL23592243 0.93 ALK (0.33) CNR1CNR2ALKITGA4NAPEPLD
SCHEMBL23592343 0.93 S1PR5 (0.35) S1PR5S1PR4CNR1CNR2CHRNA1
SCHEMBL23593071 0.90 ALK (0.35) S1PR5S1PR4CNR1CNR2CHRNA1
SCHEMBL23592245 0.90 ALK (0.32) CNR1CNR2ALKITGA4NAPEPLD
SCHEMBL23593196 0.90 S1PR5 (0.34) S1PR5S1PR4CNR1CNR2CHRNA1
SCHEMBL23593060 0.90 ALK (0.33) S1PR5S1PR4CNR1CNR2CHRNA1
SCHEMBL23593162 0.89 RARA (0.32) CNR1CNR2ALKITGA4NAPEPLD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230048456-A1 ORGANIC LIGHT-EMITTING ELEMENT AND COMPOSITION FOR ORGANIC MATERIAL LAYER THEREOF LT MATERIALS CO., LTD. (KR) 2023-02-16 — — US disclosed
US-20230016632-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO.,LTD. (KR) 2023-01-19 — — US disclosed
WO-2021132930-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE 엘티소재주식회사 2021-07-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230016632-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE CYP1A1, CYP1B1, CRY1 S1PR5 4871/4885S1PR4 4859/4885CNR1 910/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.